Sleeve Gastrectomy Decreases Body Weight, Whole-Body Adiposity, and Blood Pressure Even in Aged Diet-Induced Obese Rats

Obesity Surgery

Volumn 26, Issue 7, 2016, Pages 1549-1558

  Moncada, Rafael ^a,b,c   Rodríguez, Amaia ^a,b,c   Becerril, Sara ^a,b,c   Méndez Giménez, Leire ^a,b,c   Valentí, Víctor ^a,b,c   Ramírez, Beatriz ^a,b,c   Cienfuegos, Javier A ^a,b,c   Fernández, Secundino ^a,b,c   Catalán, Victoria ^a,b,c   Gómez Ambrosi, Javier ^b,c   Frühbeck, Gema ^a,b,c  

^a Instituto de Salud Carlos III   (Spain)

^b Recinto de Complejo Hospitalario de Navarra   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Aging; Diet induced obesity; Experimental models of bariatric surgery; Hypertension; Sleeve gastrectomy

Indexed keywords

CHOLESTEROL; GHRELIN; GLUCOSE; GLYCEROL; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET INDUCED OBESITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEART RATE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OBESITY; PERIRENAL FAT; PLETHYSMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RAT; SLEEVE GASTRECTOMY; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGE; AGING; ANIMAL; DISEASE MODEL; GASTRECTOMY; PATHOPHYSIOLOGY; PHYSIOLOGY; WEIGHT REDUCTION; WISTAR RAT;

ADIPOSITY; AGE FACTORS; AGING; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODELS, ANIMAL; GASTRECTOMY; MALE; OBESITY; RATS; RATS, WISTAR; WEIGHT LOSS;

EID: 84944705880     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1919-9     Document Type: Article

References (72)

1. Frühbeck G, Toplak H, Woodward E, et al. Obesity: the gateway to ill health—an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts. 2013;6(2):117–20.
2. Fakhouri TH, Ogden CL, Carroll MD, et al. Prevalence of obesity among older adults in the United States, 2007–2010. NCHS Data Brief. 2012;2012(106):1–8.
3. Apovian CM, Gokce N. Obesity and cardiovascular disease. Circulation. 2012;125(9):1178–82.
4. Zamboni M, Mazzali G, Zoico E, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes. 2005;29(9):1011–29.
5. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925–32.
6. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.
7. Sjöström CD, Lystig T, Lindroos AK. Impact of weight change, secular trends and ageing on cardiovascular risk factors: 10-year experiences from the SOS study. Int J Obes. 2011;35(11):1413–20.
8. Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24(1):42–55.
9. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013;21 Suppl 1:S1–27.
10. Rosenthal RJ, Diaz AA, Arvidsson D, et al. International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 cases. Surg Obes Relat Dis. 2012;8(1):8–19.
11. Gagner M, Deitel M, Erickson AL, et al. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg. 2013;23(12):2013–7.
12. de Bona CJ, Bettiol J, D’Acampora AJ, et al. Sleeve gastrectomy model in Wistar rats. Obes Surg. 2007;17(7):957–61.
13. Valentí V, Martín M, Ramírez B, et al. Sleeve gastrectomy induces weight loss in diet-induced obese rats even if high-fat feeding is continued. Obes Surg. 2011;21(9):1438–43.
14. Wilson-Perez HE, Seeley RJ. The effect of vertical sleeve gastrectomy on a rat model of polycystic ovarian syndrome. Endocrinology. 2011;152(10):3700–5.
15. Rodríguez A, Becerril S, Valentí V, et al. Sleeve gastrectomy reduces blood pressure in obese (fa/fa) Zucker rats. Obes Surg. 2012;22(2):309–15.
16. Rodríguez A, Becerril S, Valentí V, et al. Short-term effects of sleeve gastrectomy and caloric restriction on blood pressure in diet-induced obese rats. Obes Surg. 2012;22(9):1481–90.
17. Frühbeck G, Alonso R, Marzo F, et al. A modified method for the indirect quantitative analysis of phytate in foodstuffs. Anal Biochem. 1995;225(2):206–12.
18. Becerril S, Rodríguez A, Catalán V, et al. Deletion of inducible nitric-oxide synthase in leptin-deficient mice improves brown adipose tissue function. PLoS ONE. 2010;5(6):e10962.
19. Lancha A, Moncada R, Valentí V, et al. Effect of sleeve gastrectomy on osteopontin circulating levels and expression in adipose tissue and liver in rats. Obes Surg. 2014;24(10):1702–8.
20. Muruzábal FJ, Frühbeck G, Gómez-Ambrosi J, et al. Immunocytochemical detection of leptin in non-mammalian vertebrate stomach. Gen Comp Endocrinol. 2002;128(2):149–52.
21. Bell LN, Wang J, Muralidharan S, et al. Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. Hepatology. 2012;56(4):1311–8.
22. Fontana L, Kennedy BK, Longo VD, et al. Medical research: treat ageing. Nature. 2014;511(7510):405–7.
23. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.
24. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2012;273(3):219–34.
25. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.
26. Quebbemann B, Engstrom D, Siegfried T, et al. Bariatric surgery in patients older than 65 years is safe and effective. Surg Obes Relat Dis. 2005;1(4):389–92.
27. Stefater MA, Pérez-Tilve D, Chambers AP, et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology. 2010;138(7):2426–36.
28. Schneck AS, Iannelli A, Patouraux S, et al. Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots. Surg Endosc. 2014;28(2):592–602.
29. Zhou D, Jiang X, Ding W, et al. Impact of bariatric surgery on ghrelin and obestatin levels in obesity or type 2 diabetes mellitus rat model. J Diabetes Res. 2014;2014:569435.
30. Flum DR, Salem L, Elrod JA, et al. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA. 2005;294(15):1903–8.
31. Kral JG, Otterbeck P, Touza MG. Preventing and treating the accelerated ageing of obesity. Maturitas. 2010;66(3):223–30.
32. Soto FC, Gari V, de la Garza JR, et al. Sleeve gastrectomy in the elderly: a safe and effective procedure with minimal morbidity and mortality. Obes Surg. 2013;23(9):1445–9.
33. Burchett MA, McKenna DT, Selzer DJ, et al. Laparoscopic sleeve gastrectomy is safe and effective in elderly patients: a comparative analysis. Obes Surg. 2015;25(2):222–8.
34. Mizrahi I, Alkurd A, Ghanem M, et al. Outcomes of laparoscopic sleeve gastrectomy in patients older than 60 years. Obes Surg. 2014;24(6):855–60.
35. Spaniolas K, Trus TL, Adrales GL, et al. Early morbidity and mortality of laparoscopic sleeve gastrectomy and gastric bypass in the elderly: a NSQIP analysis. Surg Obes Relat Dis. 2014;10(4):584–8.
36. Sengupta P. The laboratory rat: relating its age with human's. Int J Prev Med. 2013;4(6):624–30.
37. Frühbeck G, Díez Caballero A, Gil MJ. Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med. 2004;350(3):308–9.
38. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908–13.
39. Nogueiras R, Pfluger P, Tovar S, et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology. 2007;148(1):21–6.
40. López M, Lage R, Saha AK, et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab. 2008;7(5):389–99.
41. Rodríguez A, Gómez-Ambrosi J, Catalán V, et al. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes. 2009;33(5):541–52.
42. Miegueu P, Pierre DS, Broglio F, et al. Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem. 2011;112:704–14.
43. Gurriarán-Rodríguez U, Al-Massadi O, Crujeiras AB, et al. Preproghrelin expression is a key target for insulin action on adipogenesis. J Endocrinol. 2011;210(2):R1–7.
44. Rodriguez A. Novel molecular aspects of ghrelin and leptin in the control of adipobiology and the cardiovascular system. Obes Facts. 2014;7(2):82–95.
45. Chambers AP, Jessen L, Ryan KK, et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology. 2011;141(3):950–8.
46. Kadera BE, Portenier DD, Yurcisin BM, et al. Evidence for a metabolic mechanism in the improvement of type 2 diabetes after sleeve gastrectomy in a rodent model. Surg Obes Relat Dis. 2013;9(3):447–52.
47. Rizzello M, Abbatini F, Casella G, et al. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg. 2010;20(1):50–5.
48. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.
49. Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013;36(8):2175–82.
50. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care. 2010;33(3):562–8.
51. Willey KA, Singh MA. Battling insulin resistance in elderly obese people with type 2 diabetes: bring on the heavy weights. Diabetes Care. 2003;26(5):1580–8.
52. Eckel RH, Krauss RM. American heart association call to action: obesity as a major risk factor for coronary heart disease. AHA nutrition committee. Circulation. 1998;97(21):2099–100.
53. Zhang H, Pu Y, Chen J, et al. Gastrointestinal intervention ameliorates high blood pressure through antagonizing overdrive of the sympathetic nerve in hypertensive patients and rats. J Am Heart Assoc. 2014;3(5):e000929.
54. Seravalle G, Colombo M, Perego P, et al. Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients. Hypertension. 2014;64(2):431–7.
55. Erdos B, Kirichenko N, Whidden M, et al. Effect of age on high-fat diet-induced hypertension. Am J Physiol Heart Circ Physiol. 2011;301(1):H164–72.
56. Rodríguez A, Fortuño A, Gómez-Ambrosi J, et al. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology. 2007;148(1):324–31.
57. Zeidan A, Hunter JC, Javadov S, et al. mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy. Mol Cell Biochem. 2011;352(1-2):99–108.
58. Rajapurohitam V, Izaddoustdar F, Martinez-Abundis E, et al. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation. Cell Signal. 2012;24(12):2283–90.
59. Nickola MW, Wold LE, Colligan PB, et al. Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO Hypertension. 2000;36(4):501–5.
60. Dong F, Zhang X, Ren J. Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway. Hypertension. 2006;47(2):222–9.
61. Rodríguez A, Gómez-Ambrosi J, Catalán V, et al. Vasodilator effect of ghrelin in the rat aorta. Endocrinol Nutr. 2008;55(10):448–53.
62. Kawczynska-Drozdz A, Olszanecki R, Jawien J, et al. Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats. Am J Hypertens. 2006;19(7):764–7.
63. Tesauro M, Schinzari F, Rovella V, et al. Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. Hypertension. 2009;54(5):995–1000.
64. Rodríguez A, Gómez-Ambrosi J, Catalán V, et al. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. J Hypertens. 2010;28(3):560–7.
65. Frühbeck G. Bariatric and metabolic surgery: a shift in eligibility and success criteria. Nat Rev Endocrinol. 2015;11(8):465–77.
66. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656–60.
67. Frühbeck G, Diez-Caballero A, Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg. 2004;14:606–12.
68. Chen HY, Trumbauer ME, Chen AS, et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology. 2004;145(6):2607–12.
69. Toshinai K, Yamaguchi H, Sun Y, et al. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology. 2006;147(5):2306–14.
70. Papamargaritis D, le Roux CW, Sioka E, et al. Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2013;9(2):192–201.
71. Jiménez A, Mari A, Casamitjana R, et al. GLP-1 and glucose tolerance after sleeve gastrectomy in morbidly obese subjects with type 2 diabetes. Diabetes. 2014;63(10):3372–7.
72. Baraboi ED, Li W, Labbe SM, et al. Metabolic changes induced by the biliopancreatic diversion in diet-induced obesity in male rats: the contributions of sleeve gastrectomy and duodenal switch. Endocrinology. 2015;156(4):1316–29.